Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06457438

Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
University Hospital Ostrava · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.

Detailed description

At the Department of Laboratory Medicine of the Faculty of Medicine of the Faculty of Medicine of the National University of Health Sciences, human tissue and cells from donors will be examined for the assessment of health eligibility and donor selection according to Decree No. 422/2008 Coll. According to the current legislation, the determination of IgG and IgM antibodies against HEV or the HEV RNA method is not part of the standard examination of human tissue and cell donors for the assessment of their health eligibility.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTElecsys Anti-HEV IgG, IgMDiagnostic test used to determine antibodies in blood and serum.

Timeline

Start date
2022-01-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2024-06-13
Last updated
2024-06-13

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT06457438. Inclusion in this directory is not an endorsement.